PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-898.60
Negative P/E while Healthcare median is -2.31. Seth Klarman would scrutinize path to profitability versus peers.
1802.70
P/S exceeding 1.5x Healthcare median of 11.25. Jim Chanos would check for potential multiple compression risks.
132.70
P/B exceeding 1.5x Healthcare median of 2.84. Jim Chanos would check for potential asset write-down risks.
-859.50
Negative FCF while Healthcare median P/FCF is -13.12. Seth Klarman would investigate cash flow improvement potential.
-2687.08
Negative operating cash flow while Healthcare median P/OCF is -5.54. Seth Klarman would investigate operational improvement potential.
132.70
Fair value ratio exceeding 1.5x Healthcare median of 2.86. Jim Chanos would check for valuation bubble risks.
-0.03%
Negative earnings while Healthcare median yield is -0.61%. Seth Klarman would investigate path to profitability.
-0.12%
Negative FCF while Healthcare median yield is -0.46%. Seth Klarman would investigate cash flow improvement potential.